Cargando…

Comprehensive study of dexamethasone on albumin biogenesis during normal and pathological renal conditions

CONTEXT: Dexamethasone (DXM) has an anti-immunoinflammatory effect, and is often used in acute kidney injury (AKI). However, the effects of DXM on albumin (ALB) have not been fully studied. OBJECTIVE: To investigate the effects of DXM on ALB production and renal function. MATERIALS AND METHODS: Male...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Qin, Yin, Jilei, Wang, Mulan, He, Luling, Lei, Fan, Luo, Yingying, Yang, Shilin, Feng, Yulin, Li, Jun, Du, Lijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751422/ https://www.ncbi.nlm.nih.gov/pubmed/33332210 http://dx.doi.org/10.1080/13880209.2020.1855214

Ejemplares similares

Anemoside B4 Exerts Hypoglycemic Effect by Regulating the Expression of GLUT4 in HFD/STZ Rats
por: Gong, Qin, et al.
Publicado: (2023)

Comparison of the TLR4/NFκB and NLRP3 signalling pathways in major organs of the mouse after intravenous injection of lipopolysaccharide
por: Gong, Qin, et al.
Publicado: (2019)

The abrupt pathological deterioration of cisplatin‐induced acute kidney injury: Emerging of a critical time point
por: Gong, Qin, et al.
Publicado: (2021)

Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions
por: Fader Kaiser, Claudio M., et al.
Publicado: (2022)

The human renal lymphatics under normal and pathological conditions
por: Ishikawa, Y, et al.
Publicado: (2006)

THE ACTION OF HEPATIC, RENAL AND OTHER CELLS ON PHENOL AND INDOL, UNDER NORMAL AND PATHOLOGICAL CONDITIONS
por: Herter, C. A., et al.
Publicado: (1899)

The Heart Sounds in Normal and Pathological Conditions
Publicado: (1939)

Isolation and Identification of the Anti-Oxidant Constituents from Loropetalum chinense (R. Brown) Oliv. Based on UHPLC–Q-TOF-MS/MS
por: Chen, Haifang, et al.
Publicado: (2018)

Hydrogen Sulfide: Biogenesis, Physiology, and Pathology
por: Bian, Jin-Song, et al.
Publicado: (2016)

Proteolytic System in Normal and Various Pathological Conditions
por: Iyengar, N. K., et al.
Publicado: (1942)

Markers of Endothelial Cells in Normal and Pathological Conditions
por: Goncharov, N. V., et al.
Publicado: (2020)

Shoulder biomechanics in normal and selected pathological conditions
por: Goetti, Patrick, et al.
Publicado: (2020)

Editorial: Axonal growth in normal and pathological conditions
por: Omura, Takao
Publicado: (2022)

WWOX and metabolic regulation in normal and pathological conditions
por: Baryła, Izabela, et al.
Publicado: (2022)

Expression of mTOR in normal and pathological conditions
por: Marques-Ramos, A, et al.
Publicado: (2023)

Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone
por: Wang, Di, et al.
Publicado: (2021)

Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions
por: Madel, Maria-Bernadette, et al.
Publicado: (2019)

A comprehensive landscape of 60S ribosome biogenesis factors
por: Sailer, Carolin, et al.
Publicado: (2022)

Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
por: Rao, Guocheng, et al.
Publicado: (2023)

Albuminous Conditions of the Blood, Etc.
Publicado: (1877)

Mechanisms Underlying Brain Aging Under Normal and Pathological Conditions
por: Jin, Menglong, et al.
Publicado: (2022)

Understanding Sleep Regulation in Normal and Pathological Conditions, and Why It Matters
por: Nollet, Mathieu, et al.
Publicado: (2023)

The comprehensive role of apoptosis inhibitor of macrophage (AIM) in pathological conditions
por: Yang, Huiqing, et al.
Publicado: (2022)

Therapeutic effects of baicalein on rotenone-induced Parkinson’s disease through protecting mitochondrial function and biogenesis
por: Zhang, Xue, et al.
Publicado: (2017)

Extracellular Vesicles: How Drug and Pathology Interfere With Their Biogenesis and Function
por: Cesselli, Daniela, et al.
Publicado: (2018)

THE GROWTH OF THE OVARIAN FOLLICLE OF THE GUINEA PIG UNDER NORMAL AND PATHOLOGICAL CONDITIONS
por: Walsh, L. S. N.
Publicado: (1917)

ON THE HEXON BASES OF LIVER TISSUE UNDER NORMAL AND CERTAIN PATHOLOGICAL CONDITIONS
por: Wakeman, Alfred J.
Publicado: (1905)

Editorial: Metabolic Adaptation to Cell Growth and Proliferation in Normal and Pathological Conditions
por: Giralt, Albert, et al.
Publicado: (2017)

Dynamics of Salivary Gland AQP5 under Normal and Pathologic Conditions
por: Hosoi, Kazuo, et al.
Publicado: (2020)

Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions
por: Traiffort, Elisabeth, et al.
Publicado: (2020)

Molecular Mechanisms for Regulation of Neutrophil Apoptosis under Normal and Pathological Conditions
por: Noseykina, E. M., et al.
Publicado: (2021)

Comprehensive phenotyping of human peripheral blood B lymphocytes in pathological conditions
por: Carsetti, Rita, et al.
Publicado: (2021)

Site-Specific Albumin-Selective Ligation to Human Serum Albumin under Physiological Conditions
por: Yu, Xingjian, et al.
Publicado: (2022)

Biogenesis and function of exosome lncRNAs and their role in female pathological pregnancy
por: Wang, Min, et al.
Publicado: (2023)

Extracellular Vesicles Biogenesis, Cargo Sorting and Implications in Disease Conditions
por: Fonseka, Pamali, et al.
Publicado: (2023)

S100B Protein in the Nervous System and Cardiovascular Apparatus in Normal and Pathological Conditions
por: Donato, Rosario, et al.
Publicado: (2010)

Mechanism of calsequestrin regulation of single cardiac ryanodine receptor in normal and pathological conditions
por: Chen, Haiyan, et al.
Publicado: (2013)

The role of apelinergic system in metabolism and reproductive system in normal and pathological conditions: an overview
por: Mehri, Keyvan, et al.
Publicado: (2023)

Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions
por: Bure, Irina V., et al.
Publicado: (2023)

Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist
por: Sun, Mayu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_13d624ke310e7llsk6oge4i36c